Dachaigh › Tiotalan dreuchd › Senior Scientist I
Senior Scientist I: Tuarastalan H-1B
Chleachd 207 iarrtasan cumhaichean-obrach an tiotal dreuchd Senior Scientist I. Tuarastal bunasach meadhanach $109,221; leth meadhanach $92,456–$130,162.
Iarrtasan (LCAs)207
Tuarastal meadhanach a chaidh a thabhann$109,221
Leath mheadhanach nan tuarastalan$92,456–$130,162
Ceudail 10mh–90mh$86,264–$140,000
Laghiche in-imrich, neach-faighinn no neach-fastaidh? Seall do sheirbheis aig mullach na duilleige seo — $99 airson 30 latha →
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|
| Novartis Institutes for BioMedical Research, Inc. | 68 | $91,978 |
| Schrodinger, Inc. | 17 | $130,000 |
| AbbVie Inc. | 15 | $120,000 |
| Cepheid | 9 | $130,050 |
| AbbVie Bioresearch Center Inc. | 9 | $135,000 |
| Seismic Therapeutic Inc | 6 | $141,000 |
| Eurofins Lancaster Laboratories Professional Scientific Services, LLC | 6 | $76,773 |
| Frontage Laboratories, Inc. | 6 | $83,031 |
| Prime Medicine, Inc. | 4 | $100,000 |
| 92Bio, Inc. | 3 | $130,000 |
| Danisco US Inc. | 3 | $97,700 |
| Simcere of America Inc. | 2 | $140,000 |
| Voyager Therapeutics, Inc. | 2 | $134,034 |
| Tris Pharma, Inc. | 2 | $115,564 |
| Simcere Zaiming Inc | 2 | $130,000 |
| Accurant Biotech, Inc. | 2 | $96,713 |
| Beam Therapeutics, Inc. | 2 | $127,500 |
| Navigate BioPharma Services, Inc. | 2 | $91,957 |
| GigaMune, Inc | 2 | $130,500 |
| Arrowhead Madison, Inc. | 2 | $102,232 |
| Cytokinetics, Inc. | 2 | $142,218 |
| E Ink Corporation | 2 | $123,602 |
| Dicerna Pharmaceuticals, Inc. | 2 | $147,500 |
| Abbvie Biotherapeutics Inc. | 2 | $144,000 |
| Mammoth Biosciences Inc. | 2 | $117,500 |
| Pharmaceutical Associates, Inc. | 1 | $90,000 |
| Crystal Pharmatech Inc. | 1 | $105,000 |
| LakePharma, Inc. | 1 | $102,000 |
| Mitochondria Emotion, Inc. | 1 | $150,000 |
| WuXi Biologics USA, LLC | 1 | $99,000 |
| Novo Nordisk, Inc. | 1 | $150,000 |
| Cytec Industries, Inc. | 1 | $105,000 |
| Sanegene Bio USA Inc. | 1 | $112,700 |
| Boston Institute of Biotechnology LLC | 1 | $100,000 |
| Lapix Therapeutics, Inc. | 1 | $112,500 |
| Elkem Silicones USA Corp. | 1 | $100,000 |
| Intercontinental Great Brands LLC | 1 | $101,603 |
| Nutrition & Biosciences, USA 4, Inc. | 1 | $109,803 |
| Solae, LLC | 1 | $80,184 |
| XenoBiotic Laboratories, Inc., a div. of WuXi | 1 | $100,000 |
| Alcami Carolinas Corporation | 1 | $90,000 |
| Nimble Therapeutics Inc. | 1 | $125,000 |
| Pharmaron (Boston) Lab Services, LLC | 1 | $97,760 |
| BASF Corporation | 1 | $143,699 |
| Dren Bio, Inc. | 1 | $144,000 |
| AIR Worldwide Corporation | 1 | $117,955 |
| Dren Bio Management, Inc. | 1 | — |
| Novo Nordisk Research & Development US, Inc. | 1 | $163,800 |
| Generate Biomedicines, Inc. | 1 | $140,000 |
| Givaudan Flavors Corporation | 1 | $139,000 |
| Alltrna, Inc. | 1 | $126,000 |
| Abbott Diabetes Care Inc. | 1 | $139,000 |
| Entrada Therapeutics, Inc. | 1 | $152,000 |
| Altos Labs Inc. | 1 | $199,400 |
| Halozyme Hypercon, Inc. | 1 | $101,026 |
| Sanofi US Services Inc. | 1 | $106,870 |
| Eurofins Professional Scientific Services Mid-Atlantic, LLC. | 1 | $80,954 |
| QLD Biotherapeutics Inc. | 1 | $136,900 |
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|
| Ìre I (innte) | $124,800 |
| Ìre II (càileachail) | $96,242 |
| Ìre III (eòlach) | $130,000 |
| Ìre IV (gu lèir comasach) | $136,650 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
A rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|
| FY2023 | 56 | $110,536 |
| FY2024 | 50 | $106,215 |
| FY2025 | 52 | $107,099 |
| FY2026 | 40 | $122,500 |
Bailtean
- Cambridge, MA73
- Emeryville, CA13
- North Chicago, IL13
- Sunnyvale, CA10
- New York, NY10
- San Diego, CA8
- Worcester, MA6
- Lexington, MA5
- Boston, MA5
- Exton, PA5
- Watertown, MA4
- South San Francisco, CA4
- Cranbury, NJ3
- Madison, WI3
- Hayward, CA3
- Monmouth Junction, NJ2
- San Carlos, CA2
- Woburn, MA2
- Carlsbad, CA2
- San Francisco, CA2
- Billerica, MA2
- Malvern, PA2
- Brisbane, CA2
- Palo Alto, CA2
- Greenville, SC1
- Portland, OR1
- Bothell, WA1
- Stamford, CT1
- Madision, WI1
- Southborough, MA1
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).